Parker Hannifin (PH) › Analysis

Parker Hannifin (PH) stock analysis, November 20, 2026: bearish outlook, low conviction

Published November 20, 2026 · PH chart, levels and live analysis

After a record‑breaking first‑quarter earnings beat and a strategic rebrand of its Midwest distributor, Parker‑Hannifin (PH) slipped to $888.55, down 8.7% from its recent peak of $972.9 on November 11. The daily price action follows the weekly downtrend, and the balance of evidence keeps the short‑term stance bearish with low conviction for the next two to six weeks.

Why it matters

The earnings release on November 6 showed FY2027 organic growth of 9% and adjusted EPS of $8.90, driven by the Filtration Group acquisition and strong aerospace demand Seeking Alpha. Management raised its full‑year outlook, and analysts collectively rated the stock as a buy, with a mean price target of $1,138, roughly 22% above the current price. Yet the market reaction was sharply negative, with the stock falling 7% over five days while the S&P 500 lost 6.2% in the same period, indicating that the broader market drag outweighed the earnings lift.

Volume on the decline was 77% below its 20‑day average, suggesting limited buying pressure and a lack of conviction among participants. The RSI sits at 39, edging toward oversold territory but not yet signaling a clear reversal. The price remains below both the 50‑day ($941.9) and 200‑day ($948.3) simple moving averages, confirming that the longer‑term trend is still down.

Two sides of the debate have emerged. A Nasdaq article highlighted PH as a dividend‑growth candidate, arguing that its low yield is misleading and that the stock offers attractive income potential NASDAQ. Conversely, Investing.com reported an 8.1% intraday drop on October 22, citing a downgrade from buy to hold and concerns that the valuation has outpaced fundamentals Investing.com. The latter view aligns with the current price action, which has not recovered from the post‑earnings sell‑off.

Sector‑wide, industrial manufacturing is seeing a tenth consecutive month of expansion, with the ISM Manufacturing PMI at 55.5 in October NASDAQ. However, margin pressure from input‑cost inflation and labor shortages tempers the upside. The broader market backdrop—SPY down 6.2% over five days—has also contributed to PH’s weakness.

What the evidence says

On the long‑term view, the downtrend remains intact. The price is still below its 40‑week average, and the 52‑week range shows the stock sitting 17.3% below the high and 8.4% above the low, indicating that the downside bias is unchanged. The earnings beat and strategic acquisition have not altered the structural weakness, so the long‑term thesis stays bearish.

For the next two to six weeks, the balance of evidence leans negative, but conviction is low because only one of four conviction points is satisfied—the daily trend runs with the weekly downtrend. The other point—PH leading the S&P 500 over 50 days with a +1.3% relative outperformance—does not offset the dominant downtrend. The math shows a downside breakout target at $862.5 (reward‑to‑risk 0.6) and a deeper target at $819.4 (reward‑to‑risk 2.1), but the setup does not meet a 3‑to‑1 reward‑to‑risk ratio, limiting confidence.

The strongest case against a bearish short‑term view is the +1.3% relative outperformance versus the S&P 500 over 50 days, suggesting some resilience. Yet that figure is modest and does not change the fact that the stock closed below the swing‑zone support at $879.3 and remains under the $900 round level where sellers have historically stepped in.

Levels that matter

The structure holds the price below $900, a round level that has repeatedly acted as a ceiling on rallies. The weekly trend would be considered ended if a close above $936.8—identified as a swing‑zone high—occurs, which would signal a potential shift in momentum.

A downside breakout is defined by a daily close beneath $879.3, the swing‑zone support. The stop is set at $908.1, derived from a $900 round base plus a quarter of the 14‑day ATR ($32.36). Targets are $862.5 (based on the swing‑zone) and $819.4 (the 52‑week low). Because the reward‑to‑risk does not reach 3‑to‑1, a price move to roughly $842 would be needed to achieve that threshold.

What would change the picture

A weekly close above $936.8 would invalidate the current bearish outlook, as that level is the rule for a picture change. A material development such as a new multi‑year contract in the sterile filtration market—where the sector is projected to grow to $10.1 billion by 2030 GlobeNewswire—could also shift sentiment.

What to watch

Get a message when the PH picture changes — the agent team watches the levels and the news for you.Create a free account

More PH analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.